Bilezikian JP - Search Results

1

Catabolic and anabolic actions of parathyroid hormone on the skeleton.

Silva BC, Costa AG, Cusano NE, Kousteni S, Bilezikian JP. Silva BC, et al. Among authors: bilezikian jp. J Endocrinol Invest. 2011 Nov;34(10):801-10. doi: 10.3275/7925. Epub 2011 Sep 23. J Endocrinol Invest. 2011. PMID: 21946081 Free PMC article. Review.

2

Suppression of parathyroid hormone secretion with oral calcium in normal subjects and patients with primary hyperparathyroidism.

Tohme JF, Bilezikian JP, Clemens TL, Silverberg SJ, Shane E, Lindsay R. Tohme JF, et al. Among authors: bilezikian jp. J Clin Endocrinol Metab. 1990 Apr;70(4):951-6. doi: 10.1210/jcem-70-4-951. J Clin Endocrinol Metab. 1990. PMID: 2318950

3

Primary hyperparathyroidism and parathyroid hormone-related protein.

Horwitz MJ, Bilezikian JP. Horwitz MJ, et al. Among authors: bilezikian jp. Curr Opin Rheumatol. 1994 May;6(3):321-8. doi: 10.1097/00002281-199405000-00014. Curr Opin Rheumatol. 1994. PMID: 8060769 Review.

4

Parathyroid hormone. Does it have a role in the pathogenesis of osteoporosis?

Bilezikian JP, Silverberg SJ. Bilezikian JP, et al. Clin Lab Med. 2000 Sep;20(3):559-67, vii. Clin Lab Med. 2000. PMID: 10986621 Review.

5

Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers.

Kurland ES, Cosman F, McMahon DJ, Rosen CJ, Lindsay R, Bilezikian JP. Kurland ES, et al. Among authors: bilezikian jp. J Clin Endocrinol Metab. 2000 Sep;85(9):3069-76. doi: 10.1210/jcem.85.9.6818. J Clin Endocrinol Metab. 2000. PMID: 10999788 Clinical Trial.

6

Therapy of male osteoporosis with parathyroid hormone.

Bilezikian JP, Kurland ES. Bilezikian JP, et al. Calcif Tissue Int. 2001 Oct;69(4):248-51. doi: 10.1007/s00223-001-1041-y. Calcif Tissue Int. 2001. PMID: 11730261 Review.

7

The anabolic effects of parathyroid hormone.

Rubin MR, Cosman F, Lindsay R, Bilezikian JP. Rubin MR, et al. Among authors: bilezikian jp. Osteoporos Int. 2002;13(4):267-77. doi: 10.1007/s001980200026. Osteoporos Int. 2002. PMID: 12030541 Review. No abstract available.

8

The anabolic effects of parathyroid hormone therapy.

Rubin MR, Bilezikian JP. Rubin MR, et al. Among authors: bilezikian jp. Clin Geriatr Med. 2003 May;19(2):415-32. doi: 10.1016/s0749-0690(02)00074-5. Clin Geriatr Med. 2003. PMID: 12916294 Review.

9

The importance of bisphosphonate therapy in maintaining bone mass in men after therapy with teriparatide [human parathyroid hormone(1-34)].

Kurland ES, Heller SL, Diamond B, McMahon DJ, Cosman F, Bilezikian JP. Kurland ES, et al. Among authors: bilezikian jp. Osteoporos Int. 2004 Dec;15(12):992-7. doi: 10.1007/s00198-004-1636-z. Epub 2004 Jun 3. Osteoporos Int. 2004. PMID: 15175844

10

Parathyroid hormone as an anabolic skeletal therapy.

Rubin MR, Bilezikian JP. Rubin MR, et al. Among authors: bilezikian jp. Drugs. 2005;65(17):2481-98. doi: 10.2165/00003495-200565170-00005. Drugs. 2005. PMID: 16296873 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

640 results

Search Page

Filters